298 related articles for article (PubMed ID: 16045919)
1. Nucleomorphometric analysis of canine cutaneous mast cell tumours.
Maiolino P; Cataldi M; Paciello O; Restucci B; De Vico G
J Comp Pathol; 2005; 133(2-3):209-11. PubMed ID: 16045919
[TBL] [Abstract][Full Text] [Related]
2. Morphometry of canine cutaneous mast cell tumors.
Strefezzi Rde F; Xavier JG; Catão-Dias JL
Vet Pathol; 2003 May; 40(3):268-75. PubMed ID: 12724567
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.
Weisse C; Shofer FS; Sorenmo K
J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319
[TBL] [Abstract][Full Text] [Related]
5. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
[TBL] [Abstract][Full Text] [Related]
6. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
Fröberg GK; Lindberg R; Ritter M; Nordlind K
J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
8. Nuclear morphometry in canine acanthomatous ameloblastomas and squamous cell carcinomas.
Martano M; Damiano S; Restucci B; Paciello O; Russo V; Maiolino P
Eur J Histochem; 2006; 50(2):125-30. PubMed ID: 16864123
[TBL] [Abstract][Full Text] [Related]
9. Use of quantitative analysis as a method for differentiation between canine cutaneous apocrine adenomas and apocrine carcinomas on cytological smears.
Simeonov RS; Simeonova GP
J Vet Med A Physiol Pathol Clin Med; 2007 Nov; 54(9):542-4. PubMed ID: 17931233
[TBL] [Abstract][Full Text] [Related]
10. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
11. Nuclear morphometry in squamous cell carcinomas of canine skin.
Maiolino P; Restucci B; Papparella S; De Vico G
J Comp Pathol; 2002; 127(2-3):114-7. PubMed ID: 12354521
[TBL] [Abstract][Full Text] [Related]
12. Morphometrical approach for predicting regional lymph node micrometastatic load in canine mast cell tumours: preliminary results.
Marconato L; Marchetti V; Francione D; Masserdotti C; Gregori M; Leotta R; Abramo F
Vet Comp Oncol; 2008 Sep; 6(3):162-70. PubMed ID: 19178676
[TBL] [Abstract][Full Text] [Related]
13. Computer-assisted nuclear morphometry in the cytological evaluation of canine perianal adenocarcinomas.
Simeonov R; Simeonova G
J Comp Pathol; 2008 Nov; 139(4):226-30. PubMed ID: 18822421
[TBL] [Abstract][Full Text] [Related]
14. Nucleomorphometric analysis of feline basal cell carcinomas.
Simeonov R; Simeonova G
Res Vet Sci; 2008 Jun; 84(3):440-3. PubMed ID: 17706734
[TBL] [Abstract][Full Text] [Related]
15. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis in spontaneous canine anal sac gland adenomas and carcinomas.
Simeonov R; Simeonova G
Res Vet Sci; 2008 Dec; 85(3):559-62. PubMed ID: 18457852
[TBL] [Abstract][Full Text] [Related]
17. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors.
Northrup NC; Roberts RE; Harrell TW; Allen KL; Howerth EW; Gieger TL
J Am Anim Hosp Assoc; 2004; 40(4):309-15. PubMed ID: 15238561
[TBL] [Abstract][Full Text] [Related]
18. Advances in the diagnosis and management of cutaneous mast cell tumours in dogs.
Dobson JM; Scase TJ
J Small Anim Pract; 2007 Aug; 48(8):424-31. PubMed ID: 17559522
[TBL] [Abstract][Full Text] [Related]
19. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
Taylor F; Gear R; Hoather T; Dobson J
J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
